AU2020349263B2 - Pharmaceutical composition - Google Patents

Pharmaceutical composition Download PDF

Info

Publication number
AU2020349263B2
AU2020349263B2 AU2020349263A AU2020349263A AU2020349263B2 AU 2020349263 B2 AU2020349263 B2 AU 2020349263B2 AU 2020349263 A AU2020349263 A AU 2020349263A AU 2020349263 A AU2020349263 A AU 2020349263A AU 2020349263 B2 AU2020349263 B2 AU 2020349263B2
Authority
AU
Australia
Prior art keywords
sulfate
chondroitin
nasal
patient
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020349263A
Other languages
English (en)
Other versions
AU2020349263A1 (en
Inventor
Shigeharu Fujieda
Koki FUJIKAWA
Tetsuji TAKABAYASHI
Hideki Watanabe
Kanako Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruho Co Ltd
University of Fukui NUC
Original Assignee
Maruho Co Ltd
University of Fukui NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Co Ltd, University of Fukui NUC filed Critical Maruho Co Ltd
Publication of AU2020349263A1 publication Critical patent/AU2020349263A1/en
Application granted granted Critical
Publication of AU2020349263B2 publication Critical patent/AU2020349263B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU2020349263A 2019-09-20 2020-09-18 Pharmaceutical composition Active AU2020349263B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-170955 2019-09-20
JP2019170955 2019-09-20
PCT/JP2020/035438 WO2021054440A1 (ja) 2019-09-20 2020-09-18 医薬組成物

Publications (2)

Publication Number Publication Date
AU2020349263A1 AU2020349263A1 (en) 2022-04-14
AU2020349263B2 true AU2020349263B2 (en) 2023-08-17

Family

ID=74883058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020349263A Active AU2020349263B2 (en) 2019-09-20 2020-09-18 Pharmaceutical composition

Country Status (10)

Country Link
US (1) US20220347093A1 (https=)
EP (1) EP4032535A4 (https=)
JP (1) JP7313019B2 (https=)
CN (3) CN114650828B (https=)
AU (1) AU2020349263B2 (https=)
BR (1) BR112022003464A2 (https=)
CA (1) CA3154360C (https=)
MY (1) MY206715A (https=)
PH (1) PH12022550661A1 (https=)
WO (1) WO2021054440A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3144752A1 (fr) * 2023-01-10 2024-07-12 Song Huang Utilisation de polysulfate de pentosane pour le traitement de la toux seche

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3497209B2 (ja) 1993-08-24 2004-02-16 生化学工業株式会社 硫酸化糖の脱硫酸化方法
JP3512277B2 (ja) 1995-10-05 2004-03-29 有限会社ジーオーメディカルサービス 鼻茸治療・予防剤
JPH10203988A (ja) 1997-01-27 1998-08-04 Meiji Milk Prod Co Ltd 鼻茸および鼻粘膜の浮腫性病変の治療剤
JPH11335288A (ja) * 1998-05-20 1999-12-07 Maruho Co Ltd アレルギー性疾患の予防または治療薬
WO2000069917A1 (fr) * 1999-05-18 2000-11-23 Maruho Kabushikikaisha Compositions medicinales destinees a inhiber le systeme kallikreine-kinine ou la phospholipase a¿2?
EP1922076A4 (en) 2005-08-03 2013-01-23 Morria Biopharmaceuticals USE OF LIPID CONJUGATES IN CYSTIC FIBROSIS AND ITS APPLICATIONS
US20140005115A1 (en) * 2005-11-17 2014-01-02 Yissum Research Development Company Lipid conjugates in the treatment of bronchitis
US8859524B2 (en) * 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
CA2790682C (en) 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
CN111437387B (zh) 2013-06-21 2024-10-01 赛诺菲生物技术公司 通过施用il-4r拮抗剂治疗鼻息肉症的方法
JP6637587B2 (ja) * 2015-08-04 2020-01-29 ズートツッカー アーゲー 副鼻腔炎に対するイヌリンの予防的使用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SANDEN CAROLINE, MORI MICHIKO, JOGDAND PRAJAKTA, JöNSSON JIMMIE, KRISHNAN RAVI, WANG XIANGDONG, ERJEFäLT JONAS S.: "Broad Th2 neutralization and anti-inflammatory action of pentosan polysulfate sodium in experimental allergic rhinitis : PPS neutralizes Th2 cytokines and allergic inflammation", IMMUNITY, INFLAMMATION AND DISEASE, vol. 5, no. 3, 1 September 2017 (2017-09-01), pages 300 - 309, XP055807389, ISSN: 2050-4527, DOI: 10.1002/iid3.164 *
SHINOBU SAKAI, HIROSHI AKIYAMA, YUJI SATO, YASUO YOSHIOKA, ROBERT J LINHARDT, YUKIHIRO GODA, TAMIO MAITANI, TOSHIHIKO TOIDA: J BIOL CHEM., vol. 281, no. 29, 21 July 2006 (2006-07-21), pages 19872 - 19880, XP055807386 *

Also Published As

Publication number Publication date
EP4032535A1 (en) 2022-07-27
CN114650828A (zh) 2022-06-21
CA3154360C (en) 2024-01-23
WO2021054440A1 (ja) 2021-03-25
CA3154360A1 (en) 2021-03-25
BR112022003464A2 (pt) 2022-05-24
CN118976045A (zh) 2024-11-19
CN118416094A (zh) 2024-08-02
JPWO2021054440A1 (https=) 2021-03-25
US20220347093A1 (en) 2022-11-03
MY206715A (en) 2025-01-03
EP4032535A4 (en) 2023-10-25
JP7313019B2 (ja) 2023-07-24
AU2020349263A1 (en) 2022-04-14
PH12022550661A1 (en) 2023-03-27
CN114650828B (zh) 2024-08-06

Similar Documents

Publication Publication Date Title
CA2838493C (en) Applications of partially and fully sulfated hyaluronan
US11576973B2 (en) Pharmaceutical formulations that form gel in situ
EP1385492B1 (de) Verwendung von hyaluronsäure-derivaten zur hemmung von entzündlichen arthritiden
JP2018531292A6 (ja) インサイチュでゲルを形成する医薬製剤
RU2630581C2 (ru) Защитное средство для роговицы и конъюнктивы или супрессивное средство при кератоконъюнктивальном нарушении
KR20150003868A (ko) 건조 보호 및 체류가 개선된 안과 조성물
AU2020349263B2 (en) Pharmaceutical composition
AU2003278962C1 (en) Nasal compositions comprising a mucopolysaccharide and propylene glycol
JP4961772B2 (ja) 硫酸化セルロース及びその塩から選ばれた化合物並びに皮膚炎治療剤
JP4290231B2 (ja) 角膜障害症治癒促進剤
EP3773615A1 (en) Liquid composition for use in the treatment of the mucosa of the oro-pharyngo-laryngo-esophageal tract
WO2006066500A1 (fr) Procédé de synthèse de dérivés de quinazoline et application à la fabrication d'un médicament pour le traitement d'une maladie de type tumoral
HK40109859A (zh) 药物组合物
HK40113604A (zh) 药物组合物
EP4364731A1 (en) Composition for use in the treatment of disrupted nasal mucosa and epithelial barrier
CN115209954B (zh) 用于治疗呼吸系统病变的组合物
CN1223351C (zh) 低分子量肝素在制备预防和治疗脑水肿药物中的应用
WO2020107820A1 (zh) 一种关节腔注射制剂及其应用
JP4942681B2 (ja) 角膜障害症治癒促進剤
WO2024104313A1 (en) Composition for antiviral or oxidation pretreatment, preparation method and usage method thereof
US12582685B2 (en) Uses of saccharides from prasinococcales
HK1248100B (zh) 眼用原位凝胶处方

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)